Taro-Ramipril Hctz 25 mg (Hydrochlorothiazide TABLET) 25 MG

Taro-Ramipril HCTZ 25 MG tablets combine ramipril and hydrochlorothiazide for blood pressure management. This medication is used to treat hypertension and may help reduce fluid retention.

Strength

25 MG

Manufacturer / TM Owner

SUN PHARMA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Taro-Ramipril HCTZ 25 MG tablets are commonly used for managing high blood pressure. The combination of ramipril, an ACE inhibitor, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and reducing fluid retention. This medication may be prescribed for individuals who require both types of treatment for effective blood pressure control.

Side Effects

Common effects of Taro-Ramipril HCTZ 25 MG tablets may include dizziness, fatigue, and mild nausea. Some users might experience a dry cough, which is a known side effect of ACE inhibitors. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Taro-Ramipril HCTZ 25 MG tablets should be handled with care, especially for individuals with kidney or liver issues. It's crucial to stay hydrated and avoid excessive sunlight exposure, as hydrochlorothiazide can increase sensitivity to UV rays. Regular blood pressure checks are recommended while using this medication.

Avoid Interactions

Taro-Ramipril HCTZ 25 MG tablets may interact with certain medications, including other blood pressure drugs, NSAIDs, and lithium. Alcohol consumption should be moderated, as it can enhance the blood pressure-lowering effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Taro-Ramipril HCTZ 25 MG tablets are used to manage high blood pressure by combining the effects of ramipril and hydrochlorothiazide.

Store Taro-Ramipril HCTZ 25 MG tablets at room temperature, away from moisture and heat.

Yes, dizziness is a common effect of Taro-Ramipril HCTZ 25 MG tablets, especially when starting the medication or changing the dose.

If you miss a dose, take it as soon as you remember. Skip the missed dose if it's almost time for your next dose.

It's advisable to limit salt intake and stay hydrated while taking Taro-Ramipril HCTZ 25 MG tablets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.